U.S. FDA Regulatory Matters Related to European Companies

Foley has acted for European pharmaceutical, medical device, and biotechnology companies of all sizes in all aspects of the U.S. Food and Drug Administration (FDA) regulatory review and approval process. We can assist you with your FDA compliance and enforcement actions, and conduct regulatory and IP due diligence reviews in support of your commercial transactions.